The present study, for the first time, compared the glucose‐lowering efficacy of the Equil patch insulin pump and traditional MMT‐712 insulin pump in patients with T2DM and demonstrated that these two types of insulin pumps have the same efficacy in controlling GV, including 24‐h MAGE, 24‐h SDBG, 24‐h MAXBG, and 24‐h MINBG (Table 2), as evidenced by 24‐h MBG and pre‐ and postprandial blood glucose for each meal at the same dose. The gene discussed is INS; the disease is type 2 diabetes mellitus.